Literature DB >> 18003765

Hemodialysis-induced cardiac dysfunction is associated with an acute reduction in global and segmental myocardial blood flow.

Christopher W McIntyre1, James O Burton, Nicholas M Selby, Lucia Leccisotti, Shvan Korsheed, Christopher S R Baker, Paolo G Camici.   

Abstract

BACKGROUND AND OBJECTIVES: Hemodialysis is associated with hemodynamic instability, acute cardiac ischemia, and the development of regional wall motion abnormalities (RWMAs). This study used serial intradialytic H(2)(15)O positron emission tomography scanning to confirm that the development of dialysis-induced RWMAs was associated with reduction in myocardial blood flow (MBF). DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Four prevalent hemodialysis patients without angiographically significant coronary artery disease had measurements of MBF during standard hemodialysis and biofeedback dialysis. All patients underwent serial measurements of MBF using positron emission tomography. Concurrent echocardiography was used to assess left ventricular function and the development of RWMAs. Hemodynamic variables were measured using continuous pulse wave analysis.
RESULTS: Mean prehemodialysis MBF was within the normal range. Global MBF was acutely reduced during hemodialysis. Segmental MBF was reduced to a significantly greater extent in areas that developed RWMAs compared with those that did not. Not all regions with reduced MBF were functionally affected, but a reduction in myocardial blood flow of >30% from baseline was significantly associated with the development of RWMAs. No significant differences in hemodynamic tolerability, RWMA development, or MBF between dialysis modalities were observed.
CONCLUSIONS: Hemodialysis is associated with repetitive myocardial ischemia, which, in the absence of coronary artery disease, may be due to coronary microvascular dysfunction. Stress-induced segmental left ventricular dysfunction correlates with matched reduction in MBF. Functional poststress recovery is consistent with myocardial stunning induced by hemodialysis. This process may be important in the development of heart failure in long-term hemodialysis patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18003765      PMCID: PMC2390980          DOI: 10.2215/CJN.03170707

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  37 in total

Review 1.  Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association.

Authors:  Manuel D Cerqueira; Neil J Weissman; Vasken Dilsizian; Alice K Jacobs; Sanjiv Kaul; Waren K Laskey; Dudley J Pennell; John A Rumberger; Thomas Ryan; Mario S Verani
Journal:  Int J Cardiovasc Imaging       Date:  2002-02       Impact factor: 2.357

Review 2.  Epidemiology of cardiovascular disease in chronic renal disease.

Authors:  R N Foley; P S Parfrey; M J Sarnak
Journal:  J Am Soc Nephrol       Date:  1998-12       Impact factor: 10.121

3.  Absolute blood flow and oxygen consumption in stunned myocardium in patients with coronary artery disease.

Authors:  Edward Barnes; Roger J C Hall; David P Dutka; Paolo G Camici
Journal:  J Am Coll Cardiol       Date:  2002-02-06       Impact factor: 24.094

4.  Cardiac and hemodynamic effects of hemodialysis and ultrafiltration.

Authors:  W J Bos; S Bruin; R W van Olden; I Keur; K H Wesseling; N Westerhof; R T Krediet; L A Arisz
Journal:  Am J Kidney Dis       Date:  2000-05       Impact factor: 8.860

5.  Assessment of the reproducibility of baseline and hyperemic myocardial blood flow measurements with 15O-labeled water and PET.

Authors:  P A Kaufmann; T Gnecchi-Ruscone; J T Yap; O Rimoldi; P G Camici
Journal:  J Nucl Med       Date:  1999-11       Impact factor: 10.057

6.  Effect of repeated episodes of reversible myocardial ischemia on myocardial blood flow and function in humans.

Authors:  Edward Barnes; David P Dutka; Masood Khan; Paolo G Camici; Roger J Hall
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-05       Impact factor: 4.733

7.  Blood pressure response to uncomplicated hemodialysis: the importance of changes in stroke volume.

Authors:  Diederik Boon; Gert A van Montfrans; Marion G Koopman; Raymond T Krediet; Willem Jan W Bos
Journal:  Nephron Clin Pract       Date:  2004

8.  Biofeedback controlled hemodialysis (BF-HD) reduces symptoms and increases both hemodynamic tolerability and dialysis adequacy in non-hypotension prone stable patients.

Authors:  C W McIntyre; S H Lambie; R J Fluck
Journal:  Clin Nephrol       Date:  2003-08       Impact factor: 0.975

9.  Dialysis-induced regional left ventricular dysfunction is ameliorated by cooling the dialysate.

Authors:  Nicholas M Selby; James O Burton; Lindsay J Chesterton; Christopher W McIntyre
Journal:  Clin J Am Soc Nephrol       Date:  2006-10-11       Impact factor: 8.237

Review 10.  Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients.

Authors:  Kamyar Kalantar-Zadeh; Gladys Block; Michael H Humphreys; Joel D Kopple
Journal:  Kidney Int       Date:  2003-03       Impact factor: 10.612

View more
  131 in total

1.  Improving ascertainment of sudden cardiac death in patients with end stage renal disease.

Authors:  Patrick H Pun; Charles A Herzog; John P Middleton
Journal:  Clin J Am Soc Nephrol       Date:  2011-11-10       Impact factor: 8.237

Review 2.  Incremental dialysis for preserving residual kidney function-Does one size fit all when initiating dialysis?

Authors:  Anna T Mathew; Yoshitsugu Obi; Connie M Rhee; Jason A Chou; Kamyar Kalantar-Zadeh
Journal:  Semin Dial       Date:  2018-05-07       Impact factor: 3.455

3.  Incremental dialysis in ESRD: systematic review and meta-analysis.

Authors:  Carlo Garofalo; Silvio Borrelli; Toni De Stefano; Michele Provenzano; Michele Andreucci; Gianfranca Cabiddu; Vincenzo La Milia; Valerio Vizzardi; Massimo Sandrini; Giovanni Cancarini; Adamasco Cupisti; Vincenzo Bellizzi; Roberto Russo; Paolo Chiodini; Roberto Minutolo; Giuseppe Conte; Luca De Nicola
Journal:  J Nephrol       Date:  2019-01-02       Impact factor: 3.902

4.  Heart failure management in dialysis patients: Many treatment options with no clear evidence.

Authors:  Bethany Roehm; Gaurav Gulati; Daniel E Weiner
Journal:  Semin Dial       Date:  2020-04-13       Impact factor: 3.455

Review 5.  Obesity paradox in end-stage kidney disease patients.

Authors:  Jongha Park; Seyed-Foad Ahmadi; Elani Streja; Miklos Z Molnar; Katherine M Flegal; Daniel Gillen; Csaba P Kovesdy; Kamyar Kalantar-Zadeh
Journal:  Prog Cardiovasc Dis       Date:  2013-10-09       Impact factor: 8.194

6.  The value of sequential dialysis, mannitol and midodrine in managing children prone to dialysis failure.

Authors:  Daljit K Hothi; Elizabeth Harvey; Cristina M Goia; Denis Geary
Journal:  Pediatr Nephrol       Date:  2009-03-18       Impact factor: 3.714

Review 7.  Assessment of cardiac structure and function in kidney failure: understanding echocardiography and magnetic resonance imaging for the nephrologist.

Authors:  Dharmenaan Palamuthusingam; Reza Reyaldeen; David Wayne Johnson; Camel M Hawley; Elaine M Pascoe; Sudhir Wahi; Magid Fahim
Journal:  Int Urol Nephrol       Date:  2020-08-31       Impact factor: 2.370

Review 8.  Chronic dialysis in patients with end-stage renal disease: Relevance to kidney xenotransplantation.

Authors:  Abhijit Jagdale; David K C Cooper; Hayato Iwase; Robert S Gaston
Journal:  Xenotransplantation       Date:  2018-11-20       Impact factor: 3.907

9.  Remote ischemic preconditioning in hemodialysis: a pilot study.

Authors:  Jongha Park; Soe Hee Ann; Hyun Chul Chung; Jong Soo Lee; Shin-Jae Kim; Scot Garg; Eun-Seok Shin
Journal:  Heart Vessels       Date:  2013-03-27       Impact factor: 2.037

10.  Preservation of blood pressure stability with hypertonic mannitol during hemodialysis initiation.

Authors:  Finnian R Mc Causland; Lisa M Prior; Eliot Heher; Sushrut S Waikar
Journal:  Am J Nephrol       Date:  2012-07-26       Impact factor: 3.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.